Fluzoparib increases radiation sensitivity of non-small cell lung cancer (NSCLC) cells without BRCA1/2 mutation, a novel PARP1 inhibitor undergoing clinical trials
Luo, Jing, Dai, Xinchi, Hu, Hua, Chen, Jie, Zhao, Lujun, Yang, Changyong, Sun, Jifeng, Zhang, Lianmin, Wang, Qian, Xu, Shilei, Xu, Yue, Liu, Ningbo, Ying, Guoguang, Wang, PingМова:
english
Журнал:
Journal of Cancer Research and Clinical Oncology
DOI:
10.1007/s00432-019-03097-6
Date:
November, 2019
Файл:
PDF, 2.27 MB
english, 2019
File converter
Більше результатів пошуку
More benefits 
